As the most potent antigen-presenting cells, dendritic cells (DCs) are pivotal players in regulating immune responses. DC-based technologies have generated a series of typical and promising therapeutic options, especially after the first DC-based cancer vaccine was approved by US. Food and Drug Administration (US. FDA). In this context, this paper employs patents and citation networks to conduct a fundamental analysis in order to show overall landscape of DC-based technologies. The results in this research can be used as references for decision-making in developing efficacious DC therapeutic products.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514221 | PMC |
| http://dx.doi.org/10.1080/21645515.2015.1008857 | DOI Listing |
Publication Analysis
Top Keywords
patents citation
8
citation networks
8
dc-based technologies
8
dendritic-cell-based technology
4
technology landscape
4
landscape insights
4
insights patents
4
networks potent
4
potent antigen-presenting
4
antigen-presenting cells
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!